Cargando…

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study

There are limited real-world data on the use of botulinum toxin type A (BoNT-A) in patients with multiple sclerosis (MS). Accordingly, this nationwide, population-based, retrospective cohort study aimed to describe BoNT-A treatment trends in patients with MS between 2014 and 2020 in France. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bensmail, Djamel, Karam, Pierre, Forestier, Anne, Loze, Jean-Yves, Lévy, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142089/ https://www.ncbi.nlm.nih.gov/pubmed/37104218 http://dx.doi.org/10.3390/toxins15040280

Ejemplares similares

Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France
por: Levy, Jonathan, et al.
Publicado: (2023)

Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study
por: Baccouche, Ines, et al.
Publicado: (2022)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX)
por: Supiot, Anthony, et al.
Publicado: (2018)

Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study
por: Conte, Antonella, et al.
Publicado: (2015)

New trends in botulinum toxin use in dermatology
por: Guida, Stefania, et al.
Publicado: (2018)

EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A
por: BIERING-SØRENSEN, Bo, et al.
Publicado: (2021)

Global Trends of Botulinum Toxin Literature: A Bibliometric Analysis of Botulinum Toxin Publications Between 1975 and 2017
por: Şenel, Engin, et al.
Publicado: (2020)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Synergic use of botulinum toxin injection and radial extracorporeal shockwave therapy in Multiple Sclerosis spasticity
por: Marinaro, Cinzia, et al.
Publicado: (2021)

Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis
por: Boudarham, Julien, et al.
Publicado: (2016)

Effects of botulinum toxin injection on systemic sclerosis-related digital ulcers
por: Souk, Jin-Woo, et al.
Publicado: (2019)

Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis
por: Manrique, Dayse
Publicado: (2015)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Toxin yet not toxic: Botulinum toxin in dentistry
por: Archana, M.S.
Publicado: (2016)

The Treatment of Facial Asymmetry with Botulinum Toxin: Current Concepts, Guidelines, and Future Trends
por: Heydenrych, Izolda
Publicado: (2020)

A PRACTICAL GUIDE TO OPTIMIZING THE BENEFITS OF POST-STROKE SPASTICITY INTERVENTIONS WITH BOTULINUM TOXIN A: AN INTERNATIONAL GROUP CONSENSUS
por: FRANCISCO, Gerard E., et al.
Publicado: (2020)

Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009)

Botulinum toxin: The Midas touch
por: Shilpa, P. S., et al.
Publicado: (2014)

Wound Modulation with Botulinum Toxin
por: Malik, Archana, et al.
Publicado: (2016)

Botulinum Toxin in the Treatment of Headache
por: Becker, Werner J.
Publicado: (2020)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

Botulinum Toxin for Scalp Dysesthesia
por: Phan, Kevin, et al.
Publicado: (2022)

Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022)

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022)

The Multispecialty Toxin: A Literature Review of Botulinum Toxin
por: Bach, Karen, et al.
Publicado: (2022)

Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017)

Intensive therapy after botulinum toxin in adults with spasticity after stroke versus botulinum toxin alone or therapy alone: a pilot, feasibility randomized trial
por: Lannin, Natasha A., et al.
Publicado: (2018)

Botulinum toxin type A for the management of glabellar rhytids
por: Tremaine, Anne Marie, et al.
Publicado: (2010)

Botulinum toxin: Bioweapon & magic drug
por: Dhaked, Ram Kumar, et al.
Publicado: (2010)

Therapeutic Use of Botulinum Toxin in Neurorehabilitation
por: Intiso, Domenico
Publicado: (2012)

Interaction of Botulinum Toxin with the Epithelial Barrier
por: Fujinaga, Yukako
Publicado: (2010)

Botulinum Toxin Deaths: What is the Fact?
por: Omprakash HM,, et al.
Publicado: (2008)

Application of Botulinum Toxin in Pain Management
por: Sim, Woo Seog
Publicado: (2011)

Use of botulinum toxin in musculoskeletal pain
por: Singh, Jasvinder A
Publicado: (2013)

Botulinum toxin in hemifacial spasm: Revisited
por: Singh, Sukhbir
Publicado: (2013)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bobq4npuon2upj8elphp377vh0